Disease- and sex-specific differences in patients with heart valve disease: a proteome study.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
03 2023
Historique:
received: 15 02 2022
revised: 16 12 2022
accepted: 19 12 2022
entrez: 10 1 2023
pubmed: 11 1 2023
medline: 13 1 2023
Statut: epublish

Résumé

Pressure overload in patients with aortic valve stenosis and volume overload in mitral valve regurgitation trigger specific forms of cardiac remodeling; however, little is known about similarities and differences in myocardial proteome regulation. We performed proteome profiling of 75 human left ventricular myocardial biopsies (aortic stenosis = 41, mitral regurgitation = 17, and controls = 17) using high-resolution tandem mass spectrometry next to clinical and hemodynamic parameter acquisition. In patients of both disease groups, proteins related to ECM and cytoskeleton were more abundant, whereas those related to energy metabolism and proteostasis were less abundant compared with controls. In addition, disease group-specific and sex-specific differences have been observed. Male patients with aortic stenosis showed more proteins related to fibrosis and less to energy metabolism, whereas female patients showed strong reduction in proteostasis-related proteins. Clinical imaging was in line with proteomic findings, showing elevation of fibrosis in both patient groups and sex differences. Disease- and sex-specific proteomic profiles provide insight into cardiac remodeling in patients with heart valve disease and might help improve the understanding of molecular mechanisms and the development of individualized treatment strategies.

Identifiants

pubmed: 36627164
pii: 6/3/e202201411
doi: 10.26508/lsa.202201411
pmc: PMC9834574
pii:
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Nordmeyer et al.

Références

Biochim Biophys Acta. 2014 Feb;1838(2):700-22
pubmed: 23860255
Circulation. 2006 Jun 6;113(22):2589-97
pubmed: 16735677
Int J Cardiol. 1991 May;31(2):133-41
pubmed: 1831183
JACC Cardiovasc Imaging. 2014 Nov;7(11):1073-80
pubmed: 25306541
Clin Exp Pharmacol Physiol. 2003 Aug;30(8):517-27
pubmed: 12890171
Jpn Circ J. 1993 May;57(5):434-41
pubmed: 8510313
Dev Biol. 2018 Mar 1;435(1):41-55
pubmed: 29331499
Eur Heart J. 2020 May 21;41(20):1903-1914
pubmed: 32049275
Nat Protoc. 2019 Jan;14(1):68-85
pubmed: 30464214
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
J Am Heart Assoc. 2014 Dec;3(6):e001353
pubmed: 25516438
Am J Cardiol. 1988 Jan 1;61(1):123-30
pubmed: 3337000
Cell Death Dis. 2015 Sep 03;6:e1873
pubmed: 26335715
Sci Rep. 2018 Nov 1;8(1):16213
pubmed: 30385779
Basic Res Cardiol. 2015 Mar;110(2):10
pubmed: 25653116
Circ Res. 2019 Jun 21;125(1):117-146
pubmed: 31219741
J Biol Chem. 2012 Jan 20;287(4):2666-77
pubmed: 22157761
Circ Genom Precis Med. 2018 Dec;11(12):e001974
pubmed: 30562113
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Cell Mol Biol (Noisy-le-grand). 2016 Jun 30;62(7):97-101
pubmed: 27453280
Circ Res. 2008 Mar 14;102(5):571-80
pubmed: 18202317
Circulation. 2010 Sep 14;122(11 Suppl):S23-8
pubmed: 20837918
Dis Markers. 2020 Jul 22;2020:9356738
pubmed: 32774516
Sci Rep. 2016 Nov 23;6:37635
pubmed: 27876880
J Mol Cell Cardiol. 2022 Dec;173:1-15
pubmed: 36084744
Geroscience. 2017 Feb;39(1):7-18
pubmed: 28299638
Heart. 1999 Aug;82(2):143-8
pubmed: 10409526
J Am Coll Cardiol. 2007 Feb 20;49(7):811-21
pubmed: 17306712
Biochem Biophys Res Commun. 2008 Aug 22;373(2):186-91
pubmed: 18541142
Circ Res. 2008 Dec 5;103(12):1473-82
pubmed: 18974385
Circ Res. 2013 Aug 30;113(6):709-24
pubmed: 23989714
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1375-89
pubmed: 26232232
J Clin Invest. 2018 May 1;128(5):2127-2143
pubmed: 29664017
Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H552-H562
pubmed: 29196344
Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1814-20
pubmed: 11247796
Mol Cell Proteomics. 2020 Jul;19(7):1132-1144
pubmed: 32291283
Fibrogenesis Tissue Repair. 2012 Sep 03;5(1):15
pubmed: 22943504
Eur J Heart Fail. 2014 Nov;16(11):1160-7
pubmed: 25287281
J Cell Biochem. 2011 Jul;112(7):1787-94
pubmed: 21381076
JCI Insight. 2017 Jul 20;2(14):
pubmed: 28724803
Cells. 2020 Mar 03;9(3):
pubmed: 32138230
Pulm Circ. 2015 Mar;5(1):15-28
pubmed: 25992268
JACC Basic Transl Sci. 2020 Apr 15;5(5):432-443
pubmed: 32478206
Am J Physiol Heart Circ Physiol. 2022 Nov 1;323(5):H949-H957
pubmed: 36206048
J Biol Chem. 2011 May 13;286(19):17365-75
pubmed: 21454527
Eur Heart J. 2021 Jul 15;42(27):2683-2691
pubmed: 34023890
Mol Cell Neurosci. 2018 Sep;91:160-166
pubmed: 29551667
J Am Coll Radiol. 2006 Sep;3(9):665-76
pubmed: 17412147
Heart Fail Rev. 2002 Apr;7(2):115-30
pubmed: 11988636
Circulation. 2018 Sep 18;138(12):1236-1252
pubmed: 29653926
Circ Res. 2020 Jan 17;126(2):182-196
pubmed: 31709908
Nat Commun. 2017 Nov 13;8(1):1469
pubmed: 29133944
Nat Rev Cardiol. 2017 Nov;14(11):637-653
pubmed: 28660894
Dev Cell. 2018 Feb 5;44(3):326-336.e3
pubmed: 29396114
J Cell Sci. 1993 Dec;106 ( Pt 4):1291-300
pubmed: 8126108

Auteurs

Sarah Nordmeyer (S)

Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Institute for Cardiovascular Computer-Assisted Medicine, Berlin, Germany snordmeyer@dhzb.de titus.kuehne@dhzb.de philipp.mertins@mdc-berlin.de.
Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Department of Congenital Heart Disease - Pediatric Cardiology, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

Milena Kraus (M)

Hasso Plattner Institute for Digital Engineering, Digital Health Center, University of Potsdam, Potsdam, Germany.

Matthias Ziehm (M)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Proteomics Platform, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Marieluise Kirchner (M)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Proteomics Platform, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Marie Schafstedde (M)

Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Institute for Cardiovascular Computer-Assisted Medicine, Berlin, Germany.
Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Department of Congenital Heart Disease - Pediatric Cardiology, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Marcus Kelm (M)

Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Institute for Cardiovascular Computer-Assisted Medicine, Berlin, Germany.
Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Department of Congenital Heart Disease - Pediatric Cardiology, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Sylvia Niquet (S)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Proteomics Platform, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Mariet Mathew Stephen (MM)

Hasso Plattner Institute for Digital Engineering, Digital Health Center, University of Potsdam, Potsdam, Germany.

Istvan Baczko (I)

Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.

Christoph Knosalla (C)

German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart, Department of Cardiothoracic and Vascular Surgery, Berlin, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Matthieu-P Schapranow (MP)

Hasso Plattner Institute for Digital Engineering, Digital Health Center, University of Potsdam, Potsdam, Germany.

Gunnar Dittmar (G)

Proteomics of Cellular Signaling, Luxembourg Institute of Health, Strassen, Luxembourg.

Michael Gotthardt (M)

German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Neuromuscular and Cardiovascular Cell Biology, Berlin, Germany.

Martin Falcke (M)

Max Delbrück Center for Molecular Medicine, Mathematical Cell Physiology, Berlin, Germany.

Vera Regitz-Zagrosek (V)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Department of Cardiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.

Titus Kuehne (T)

Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Institute for Cardiovascular Computer-Assisted Medicine, Berlin, Germany snordmeyer@dhzb.de titus.kuehne@dhzb.de philipp.mertins@mdc-berlin.de.
Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Department of Congenital Heart Disease - Pediatric Cardiology, Berlin, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Philipp Mertins (P)

German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany snordmeyer@dhzb.de titus.kuehne@dhzb.de philipp.mertins@mdc-berlin.de.
Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Proteomics Platform, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH